Jennifer Erwin
@jennifererwin.bsky.social
Turning genetic insights into medicine. Committed to getting therapies into humans, not lost in PDFs. Building the future of brain health with Aluco Biosciences & CCXDP—while raising two tiny humans.
🚨 We're hiring! The Erwin Lab at Flinders University Australia is looking for graduate students and postdocs passionate about neurogenetics, epigenetics & therapeutics.
Collaborate with biotech & launch a spinout.
📩 jennifer.erwin@flinders.edu.au
🔗 flinders.edu.au/people/jennifer.erwin
Collaborate with biotech & launch a spinout.
📩 jennifer.erwin@flinders.edu.au
🔗 flinders.edu.au/people/jennifer.erwin
August 5, 2025 at 8:19 PM
🚨 We're hiring! The Erwin Lab at Flinders University Australia is looking for graduate students and postdocs passionate about neurogenetics, epigenetics & therapeutics.
Collaborate with biotech & launch a spinout.
📩 jennifer.erwin@flinders.edu.au
🔗 flinders.edu.au/people/jennifer.erwin
Collaborate with biotech & launch a spinout.
📩 jennifer.erwin@flinders.edu.au
🔗 flinders.edu.au/people/jennifer.erwin
Reposted by Jennifer Erwin
We just got an email that Hopkins is freezing salaries, hiring, and some construction projects. In addition to the 800 million USAID we lost, we’ve had another 50 million in grants canceled so far. And a 2/3 year over year decline in funded grants despite an increase in submissions
June 2, 2025 at 9:02 PM
We just got an email that Hopkins is freezing salaries, hiring, and some construction projects. In addition to the 800 million USAID we lost, we’ve had another 50 million in grants canceled so far. And a 2/3 year over year decline in funded grants despite an increase in submissions
Reposted by Jennifer Erwin
Mobile DNA in aging. Will anti-retrovirals be the new statins? Intriguing discussion with John Sedivy youtu.be/oEOn5SEhvNM?...
Interview with John Sedivy
YouTube video by CSHL Leading Strand
youtu.be
June 1, 2025 at 12:55 PM
Mobile DNA in aging. Will anti-retrovirals be the new statins? Intriguing discussion with John Sedivy youtu.be/oEOn5SEhvNM?...
Reposted by Jennifer Erwin
A quick summary from the end of another long day...
Some, but not all, tenure track investigators within their first 2 years did receive termination emails. I have not yet been able to determine why some did and not others. Even with one branch, there was variability.
1/n
Some, but not all, tenure track investigators within their first 2 years did receive termination emails. I have not yet been able to determine why some did and not others. Even with one branch, there was variability.
1/n
a man in a blue shirt is smiling with the words here 's the quick recap below him
ALT: a man in a blue shirt is smiling with the words here 's the quick recap below him
media.tenor.com
February 17, 2025 at 1:43 AM
A quick summary from the end of another long day...
Some, but not all, tenure track investigators within their first 2 years did receive termination emails. I have not yet been able to determine why some did and not others. Even with one branch, there was variability.
1/n
Some, but not all, tenure track investigators within their first 2 years did receive termination emails. I have not yet been able to determine why some did and not others. Even with one branch, there was variability.
1/n
Reposted by Jennifer Erwin
holy sheeet
" Pursuant to this Supplemental Guidance, there will be a standard indirect rate of 15% across all NIH grants for indirect costs in lieu of a separately negotiated rate for indirect costs in every grant."
" Pursuant to this Supplemental Guidance, there will be a standard indirect rate of 15% across all NIH grants for indirect costs in lieu of a separately negotiated rate for indirect costs in every grant."
February 7, 2025 at 11:23 PM
holy sheeet
" Pursuant to this Supplemental Guidance, there will be a standard indirect rate of 15% across all NIH grants for indirect costs in lieu of a separately negotiated rate for indirect costs in every grant."
" Pursuant to this Supplemental Guidance, there will be a standard indirect rate of 15% across all NIH grants for indirect costs in lieu of a separately negotiated rate for indirect costs in every grant."
Reposted by Jennifer Erwin
I have learned from several sources that NIH staff tried to find out how to transfer F31-diversity applications to other program announcements for funding but were not able to do this. I don't know whether this was technical (regulations) or ideological.
1/n
1/n
February 7, 2025 at 4:01 PM
I have learned from several sources that NIH staff tried to find out how to transfer F31-diversity applications to other program announcements for funding but were not able to do this. I don't know whether this was technical (regulations) or ideological.
1/n
1/n
Reposted by Jennifer Erwin
Federal restrictions & funding freezes threaten vital research and halts scientific progress that benefits all Americans.
Join fellow #NeuroAdvocates in urging Congress to protect congressionally approved funding & ensure uninterrupted support for the scientific workforce.
👇 #NeuroSky
Join fellow #NeuroAdvocates in urging Congress to protect congressionally approved funding & ensure uninterrupted support for the scientific workforce.
👇 #NeuroSky
February 6, 2025 at 6:45 PM
Federal restrictions & funding freezes threaten vital research and halts scientific progress that benefits all Americans.
Join fellow #NeuroAdvocates in urging Congress to protect congressionally approved funding & ensure uninterrupted support for the scientific workforce.
👇 #NeuroSky
Join fellow #NeuroAdvocates in urging Congress to protect congressionally approved funding & ensure uninterrupted support for the scientific workforce.
👇 #NeuroSky
Reposted by Jennifer Erwin
We are hearing that Andy Singleton, director of a new and promising Alzheimer's research center at NIH, just announced his resignation.
This will disrupt innovative new Alzheimer's work to go beyond the "amyloid hypothesis." Bad news for anyone who's been touched by this disease. 🧪
This will disrupt innovative new Alzheimer's work to go beyond the "amyloid hypothesis." Bad news for anyone who's been touched by this disease. 🧪
February 6, 2025 at 11:27 PM
We are hearing that Andy Singleton, director of a new and promising Alzheimer's research center at NIH, just announced his resignation.
This will disrupt innovative new Alzheimer's work to go beyond the "amyloid hypothesis." Bad news for anyone who's been touched by this disease. 🧪
This will disrupt innovative new Alzheimer's work to go beyond the "amyloid hypothesis." Bad news for anyone who's been touched by this disease. 🧪
Reposted by Jennifer Erwin
Singleton works on neurodegenerative diseases like Parkinson's and Alzheimer's.
He's from the UK. He'll have plenty of job options.
These are the kind of high-skilled workers that are lost when govt is under attack.
en.m.wikipedia.org/wiki/Andrew_...
He's from the UK. He'll have plenty of job options.
These are the kind of high-skilled workers that are lost when govt is under attack.
en.m.wikipedia.org/wiki/Andrew_...
February 6, 2025 at 11:38 PM
Singleton works on neurodegenerative diseases like Parkinson's and Alzheimer's.
He's from the UK. He'll have plenty of job options.
These are the kind of high-skilled workers that are lost when govt is under attack.
en.m.wikipedia.org/wiki/Andrew_...
He's from the UK. He'll have plenty of job options.
These are the kind of high-skilled workers that are lost when govt is under attack.
en.m.wikipedia.org/wiki/Andrew_...